Literature DB >> 18844510

Mental health, binge drinking, and antihypertension medication adherence.

Jim E Banta1, Kelly B Haskard, Mark G Haviland, Summer L Williams, Leonard S Werner, Donald L Anderson, M Robin DiMatteo.   

Abstract

OBJECTIVES: To evaluate the relationship between self-reported mental health and binge drinking, as well as health status, sociodemographic, social support, economic resource, and health care access indicators to antihypertension medication adherence.
METHOD: Analysis of 2003 California Health Interview Survey data.
RESULTS: Having poor mental health days predicted medication nonadherence, whereas binge drinking did not. Nonadherence predictors included younger age, Latino, non-US citizen, uninsured, less education, and no regular medical care. Adherence predictors were older age, African American, having prescription insurance, a college degree, poor health, comorbid diabetes or heart disease, and overweight or obese.
CONCLUSION: Better mental health may improve medication adherence among hypertensive individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18844510     DOI: 10.5993/ajhb.33.2.5

Source DB:  PubMed          Journal:  Am J Health Behav        ISSN: 1087-3244


  3 in total

1.  Prevalence of HIV risk behaviors between binge drinkers and non-binge drinkers aged 18- to 64-years in US, 2008.

Authors:  Xiao-Jun Wen; Lina Balluz; Machell Town
Journal:  J Community Health       Date:  2012-02

2.  Nicotine Replacement Therapy Use Predicts Smoking and Drinking Outcomes among Heavy-Drinking Smokers Calling a Tobacco Quitline.

Authors:  Alana M Rojewski; Lisa M Fucito; Stephen Baldassarri; Andrew Hyland; K Michael Cummings; Benjamin A Toll
Journal:  J Smok Cessat       Date:  2016-05-10

3.  Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study.

Authors:  F Efficace; M Baccarani; G Rosti; F Cottone; F Castagnetti; M Breccia; G Alimena; A Iurlo; A R Rossi; S Pardini; F Gherlinzoni; M Salvucci; M Tiribelli; M Vignetti; F Mandelli
Journal:  Br J Cancer       Date:  2012-08-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.